skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery

(2750) Views  (681) Full article downloads

Authors: Helga P Sandoval, Luis E Fernández de Castro, David T Vroman, Kerry D Solomon

Published Date January 2007 Volume 2007:1(4) Pages 367 - 371
DOI: http://dx.doi.org/10.2147/OPTH.S

Helga P Sandoval, Luis E Fernández de Castro, David T Vroman, Kerry D Solomon

Magill Research Center for Vision Correction, Storm Eye Institute, Medical University of South Carolina, Charleston, SC, USA

Abstract: The non-steroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.4% ophthalmic solution, a recent reformulation containing 20% less active ingredient that the original formulation, is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Clinical studies have shown ketorolac tromethamine 0.4% to be as effective as ketorolac tromethamine 0.5% to control inflammation after cataract surgery including prevention of cystoid macular edema (CME). Its efficacy to inhibit miosis during cataract surgery as well as its role in the treatment of dry eye has been reported. The purpose of this paper is to review the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery.

Keywords: NSAIDs, anti-inflammatory, ketorolac, ocular, ophthalmic








Readers of this article also read:

Editorial: Open Access — the future of medical publishing || FREE PAPER ||
Presumed levothyroxine-induced pseudotumor cerebri in a pediatric patient being treated for congenital hypothyroidism
Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
Indocyanine green-assisted epiretinal membrane peeling evaluated by optical coherence tomography and multifocal electroretinography
Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study
Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin®) for AMD followed by controlateral sympathetic ophthalmia
A study of monofocal intraocular lens (AcrySof ®) in mini-monovision (MMV) and premium multifocal implantation of ReSTOR®
Surgical results of pars plana vitrectomy combined with pars plana lensectomy with anterior capsule preservation, endophotocoagulation, and silicon oil tamponade for neovascular glaucoma
Evaluation of tensile strength of tissue adhesives and sutures for clear corneal incisions using porcine and bovine eyes, with a novel standardized testing platform